Literature DB >> 7760719

Clinical variability in adult-onset acid maltase deficiency: report of affected sibs and review of the literature.

K J Felice1, A G Alessi, M L Grunnet.   

Abstract

Acid maltase deficiency (AMD) is a rare cause of muscle disease in adult patients. The present report of 2 sibs and review of 36 previously reported cases illustrates the vast clinical variability in adult-onset AMD. This is 1 of only 3 reports to document tongue weakness and enlargement in an adult with AMD. The presenting signs and symptoms usually include progressive limb weakness, restrictive lung disease, or both. Consistent supportive abnormalities include a modest elevation in serum CK, a reduction in the forced vital capacity, and abnormal spontaneous activity (that is, myotonic discharges or fibrillations) in resting muscles during needle electromyography. The clinical spectrum is also extended to include distal limb weakness, scapular winging, asymmetric muscle weakness, and tongue involvement.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760719     DOI: 10.1097/00005792-199505000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  9 in total

Review 1.  Inborn errors of metabolism as a cause of neurological disease in adults: an approach to investigation.

Authors:  R G Gray; M A Preece; S H Green; W Whitehouse; J Winer; A Green
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

2.  [Diagnosis and differential diagnosis of lysosomal glycogen storage disease].

Authors:  D Fischer; S Paus; R Schröder
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

3.  Isolated elevated serum transaminases leading to the diagnosis of asymptomatic Pompe disease.

Authors:  Marieke Hoeksma; Maartje Boon; Klary E Niezen-Koning; Lidy van Overbeek-van Gils; Francjan J van Spronsen
Journal:  Eur J Pediatr       Date:  2006-10-17       Impact factor: 3.183

Review 4.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

5.  Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice.

Authors:  Yunxiang Zhu; Xuemei Li; Alison McVie-Wylie; Canwen Jiang; Beth L Thurberg; Nina Raben; Robert J Mattaliano; Seng H Cheng
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

Review 6.  Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature.

Authors:  Gauthier Remiche; Dario Ronchi; Francesca Magri; Costanza Lamperti; Andreina Bordoni; Maurizio Moggio; Nereo Bresolin; Giacomo P Comi
Journal:  J Neurol       Date:  2013-10-25       Impact factor: 4.849

7.  Glycoengineered acid alpha-glucosidase with improved efficacy at correcting the metabolic aberrations and motor function deficits in a mouse model of Pompe disease.

Authors:  Yunxiang Zhu; Ji-Lei Jiang; Nathan K Gumlaw; Jinhua Zhang; Scott D Bercury; Robin J Ziegler; Karen Lee; Mariko Kudo; William M Canfield; Timothy Edmunds; Canwen Jiang; Robert J Mattaliano; Seng H Cheng
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

8.  Familial adult-onset Pompe disease associated with unusual clinical and histological features.

Authors:  Lorenzo Maggi; Franco Salerno; Cinzia Bragato; Simona Saredi; Flavia Blasevich; Elio Maccagnano; Barbara Pasanisi; Cesare Danesino; Marina Mora; Lucia Morandi
Journal:  Acta Myol       Date:  2013-10

9.  Phenotypical variation within 22 families with Pompe disease.

Authors:  Stephan C A Wens; Carin M van Gelder; Michelle E Kruijshaar; Juna M de Vries; Nadine A M E van der Beek; Arnold J J Reuser; Pieter A van Doorn; Ans T van der Ploeg; Esther Brusse
Journal:  Orphanet J Rare Dis       Date:  2013-11-19       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.